tiprankstipranks
Advertisement
Advertisement

FOLD Stock Latest News

BioMarin price target lowered to $85 from $97 at BofA
The FlyBioMarin price target lowered to $85 from $97 at BofA
28d ago
BMRN
FOLD
Amicus Stockholders Approve BioMarin Acquisition at Special Meeting
PremiumCompany Announcements
Amicus Stockholders Approve BioMarin Acquisition at Special Meeting
1M ago
8K
FOLD
BioMarin price target raised to $104 from $98 at Canaccord
PremiumThe Fly
BioMarin price target raised to $104 from $98 at Canaccord
1M ago
BMRN
FOLD
BioMarin price target lowered to $86 from $106 at Guggenheim
PremiumThe Fly
BioMarin price target lowered to $86 from $106 at Guggenheim
1M ago
BMRN
FOLD
BioMarin price target lowered to $95 from $98 at Oppenheimer
PremiumThe Fly
BioMarin price target lowered to $95 from $98 at Oppenheimer
1M ago
BMRN
FOLD
Maintaining a Hold: Solid Execution at Amicus but Limited Upside Ahead of the BioMarin Acquisition
PremiumRatingsMaintaining a Hold: Solid Execution at Amicus but Limited Upside Ahead of the BioMarin Acquisition
1M ago
FOLD
Legal Challenges Loom Over Amicus–BioMarin Merger, Raising Execution and Shareholder Risks
Premium
Company Announcements
Legal Challenges Loom Over Amicus–BioMarin Merger, Raising Execution and Shareholder Risks
2M ago
FOLD
Amicus reports Q4 EPS 10c, consensus 18c
Premium
The Fly
Amicus reports Q4 EPS 10c, consensus 18c
2M ago
FOLD
Amicus Therapeutics (FOLD) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Amicus Therapeutics (FOLD) Q4 Earnings Cheat Sheet
2M ago
FOLD
Amicus presents new long-term data for Galafold, Pombiliti+ Opfolda
PremiumThe Fly
Amicus presents new long-term data for Galafold, Pombiliti+ Opfolda
2M ago
FOLD
Amicus Therapeutics: Solid Fundamentals but Limited Upside Amid BioMarin Takeover, Justifying Hold Rating
PremiumRatings
Amicus Therapeutics: Solid Fundamentals but Limited Upside Amid BioMarin Takeover, Justifying Hold Rating
2M ago
FOLD
Madrigal, Clene, Cencora, Sequans, Amicus: Insider Moves Exposed
PremiumWeekend Updates
Madrigal, Clene, Cencora, Sequans, Amicus: Insider Moves Exposed
2M ago
COR
CLNN
Amicus downgraded to Hold from Buy at Jefferies
PremiumThe FlyAmicus downgraded to Hold from Buy at Jefferies
3M ago
FOLD
BioMarin upgraded to Buy from Hold at Canaccord
Premium
The Fly
BioMarin upgraded to Buy from Hold at Canaccord
3M ago
BMRN
FOLD
Amicus downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Amicus downgraded to Neutral from Buy at Guggenheim
3M ago
FOLD
Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal
PremiumThe Fly
Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal
3M ago
KKR
NVO
Amicus Therapeutics: Acquisition Premium Caps Upside, Driving Neutral Stance at BioMarin’s $14.50 Offer Price
PremiumRatings
Amicus Therapeutics: Acquisition Premium Caps Upside, Driving Neutral Stance at BioMarin’s $14.50 Offer Price
3M ago
FOLD
Amicus downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Amicus downgraded to Market Perform from Outperform at Leerink
3M ago
FOLD
BioMarin price target raised to $100 from $80 at Truist
PremiumThe Fly
BioMarin price target raised to $100 from $80 at Truist
4M ago
BMRN
FOLD
Arcellx initiated, Cummins upgraded: Wall Street’s top analyst calls
PremiumThe FlyArcellx initiated, Cummins upgraded: Wall Street’s top analyst calls
4M ago
CMI
SEE
BofA moves to No Rating on Amicus after BioMarin deal
Premium
The Fly
BofA moves to No Rating on Amicus after BioMarin deal
4M ago
BMRN
FOLD
Amicus downgraded to Neutral from Buy at Citi
Premium
The Fly
Amicus downgraded to Neutral from Buy at Citi
4M ago
FOLD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >